Friday, October 20, 2017 6:10:35 PM
Something to read while enjoying your morning coffee or tea over the weekend!!
http://theseedinvestor.com/articles/37-year-old-diabetes-discovery-set-to-launch-tiny-marijuana-biotech-stock
http://theseedinvestor.com/articles/37-year-old-diabetes-discovery-set-to-launch-tiny-marijuana-biotech-stock
Do your own DD. Anything I post is for entertainment purpose only and should not assist you in any trading decision based on anything I post. Further more I do not receive any compansation of any kind from any company or 3rd party mentioned in my post(
Recent INM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 09:08:05 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:51:08 PM
- /C O R R E C T I O N -- InMed Pharmaceuticals/ • PR Newswire (US) • 05/20/2026 02:34:00 PM
- /C O R R E C T I O N -- InMed Pharmaceuticals/ • PR Newswire (US) • 05/19/2026 06:21:00 PM
- InMed-Mentari Migraine Merger Backed by $290 Million Financing Reshapes Company Strategy (INM) • IH Market News • 05/19/2026 02:37:16 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/19/2026 02:34:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 02:32:30 PM
- InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies • PR Newswire (US) • 05/19/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 10:03:08 AM
- InMed Pharmaceuticals Amends Preferred Investment Options • Newsfile • 05/19/2026 10:00:00 AM
- InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update • Newsfile • 05/06/2026 10:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 09:25:11 PM
- InMed Pharmaceuticals Amends Preferred Investment Options • Newsfile • 04/27/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 08:58:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:19:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/03/2026 08:17:05 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/31/2026 04:15:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:37:48 PM
- InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance • Newsfile • 03/27/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:31:26 AM
- InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program • Newsfile • 03/23/2026 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/20/2026 09:00:29 PM
- Sidoti Events, LLC's March Small-Cap Virtual Conference • ACCESS Newswire • 03/18/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:43:44 AM
- InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial • Newsfile • 03/09/2026 11:30:00 AM
